Tafasitamab for the treatment of patients with diffuse large B-cell lymphoma

• Main Authors: Maria Cristina Pirosa (Author), Anastasios Stathis (Author), Emanuele Zucca (Author)
• Formato: Libro
• Publicado: Taylor & Francis Group, 2024-12-01T00:00:00Z.
• Subjects: article
• Acceso en liña: Connect to this object online.

ABSTRACTPatients with relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL) require additional treatments, especially those not eligible or not responding to high dose cytotoxic chemotherapy and stem cell transplantation. Over the last few years, several new treatments have been develop...